Top Markets
Coin of the day
Athens Medical C.S.A. Athens Medical C.S.A.

Athens Medical C.S.A.

IATR
株式のランク #19370
Athens Medical C.S.A., together with its affiliated companies, operates and... Athens Medical C.S.A., together with its affiliated companies, operates and holds ownership of hospital facilities both within Greece and on an international scale. The organization delivers extensive diagnostic and treatment options for various cancers, such as those affecting the breast, gastrointestinal system, blood, liver and pancreas, lungs, prostate, skin, bladder, kidneys, and female reproductive organs. Additionally, it offers advanced robotic surgery, neurosurgical procedures, spinal operations, and therapies for cardiac ailments. Its services encompass a broad range of orthopedic specialties, addressing conditions of the foot and ankle, hand and wrist, hip, knee, shoulder, and spine, in addition to treating sports-related injuries. The company also provides care for chronic conditions including diabetes, endocrine disorders, heart failure, high blood pressure, pain management, respiratory system issues, stroke, and thyroid conditions. Furthermore, Athens Medical C.S.A. runs wellness and preventative health centers and performs cosmetic and reconstructive plastic surgery. The group is also involved in medical education, training, and practical service provision, alongside offering patient care guidance. It currently manages eight hospital units, which collectively feature 1,200 beds. Founded in 1984, Athens Medical C.S.A. is headquartered in Athens, Greece.
株価
$1.90
最終同期: 2026-08-25
時価総額
$164.61M
変化(1日)
-1.23%
変化(1年)
-24.88%
GR
取引 Athens Medical C.S.A. (IATR)

カテゴリー

Athens Medical C.S.A.(IATR)のP/E比率
2026 時点のP/E比率 TTM 0
Athens Medical C.S.A. の最新の財務報告および株価によると、現在の P/E (TTM) は 0 です。2026 年末時点での P/E は 0 でした。
Athens Medical C.S.A. の P/E 比率の履歴(2026 〜 2026)
各年末のP/E比率
P/E比率 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社のP/E比率
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。